FYC - ETF AI Analysis
Top Page
First Trust Small Cap Growth AlphaDEX Fund (FYC)
FYC, the First Trust Small Cap Growth AlphaDEX Fund, has a solid but not top-tier rating, reflecting a mix of promising growth stories and meaningful financial risks among its holdings. Strong contributors like FIGS and Slide Insurance support the fund’s quality through robust revenue growth, operational efficiency, and favorable profitability and valuation. However, weaker holdings such as HeartFlow and Netskope, which face financial instability, ongoing losses, and bearish or mixed technical trends, highlight the main risk: exposure to smaller, less profitable companies that can be more volatile and financially fragile.
FYC vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.38B
- Region
- North America
- Expense Ratio
- 0.70%
- Beta
- 1.11
- Issuer
- First Trust
- Inception Date
- Apr 19, 2011
- Dividend Yield
- 0.18%
- Asset Class
- Equity
- Index Tracked
- NASDAQ AlphaDEX Small Cap Growth Index
FYC Summary
The First Trust Small Cap Growth AlphaDEX Fund (FYC) is an ETF that follows the NASDAQ AlphaDEX Small Cap Growth Index, focusing on smaller U.S. companies expected to grow quickly. It spreads investments across areas like health care, technology, and financials, with holdings such as Appian and Asana. Someone might consider FYC to seek higher long-term growth and to diversify beyond large, well-known companies. However, small-cap stocks can be very volatile, so the fund’s value can rise and fall more sharply than the overall market.
How much will it cost me?
This ETF has an expense ratio of 0.70%, which means you’ll pay about $7 per year for every $1,000 invested. That’s higher than the average ETF because it uses an actively managed, rules-based AlphaDEX strategy rather than a simple passive index.
What would affect this ETF?
FYC could benefit if the U.S. economy stays healthy, interest rates eventually ease, and innovation in sectors like health care and technology drives strong growth for small companies such as Appian and Amplitude. On the downside, higher-for-longer interest rates, economic slowdowns that hit small businesses harder, or tighter regulations in areas like health care, insurance, and real estate could weigh on the fund’s performance.
FYC Top 10 Holdings
FYC is leaning hard into U.S. small-cap growth, with a noticeable tilt toward health care and tech names that can move quickly in either direction. Rising software players like Appian and Amplitude, along with data-focused Netskope, are helping power the fund, while FIGS has been a bright spot with steady momentum. On the flip side, medically oriented names such as HeartFlow and Agilon Health are more of a headache than a help, as their lagging performance and financial growing pains weigh on returns. Overall, it’s a high-octane, domestically focused growth mix.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 APPN | Appian | 0.89% | $12.01M | $3.52B | 64.71% | 58Neutral |
 FIGS | FIGS | 0.79% | $10.61M | $3.54B | 173.56% | 74Outperform |
 AMPL | Amplitude | 0.79% | $10.64M | $2.13B | 75.18% | 52Neutral |
 SLDE | Slide Insurance Holdings, Inc. | 0.80% | $10.72M | $3.25B | 75.17% | 73Outperform |
 STGW | Stagwell | 0.82% | $11.10M | $2.60B | 124.20% | 65Neutral |
 HTFL | HeartFlow, Inc. | 0.76% | $10.24M | $5.13B | 61.47% | 40Neutral |
 NTSK | Netskope, Inc. | 0.71% | $9.62M | $9.93B | 6.02% | 47Neutral |
 LIND | Lindblad Expeditions Holdings | 0.76% | $10.25M | $2.45B | 221.98% | 53Neutral |
 FA | First Advantage | 0.78% | $10.46M | $3.71B | 66.59% | 51Neutral |
 FTRE | Fortrea Holdings Inc. | 0.68% | $9.21M | $2.05B | 112.26% | 56Neutral |
FYC Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FYC, the sentiment is Negative. The current price of 114.03 is below the 20-day moving average (MA) of 114.11, below the 50-day MA of 116.54, and above the 200-day MA of 111.82, indicating a neutral trend. The MACD of -0.41 indicates Negative momentum. The RSI at 47.12 is Neutral, neither overbought nor oversold. The STOCH value of 77.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FYC.
FYC Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| FYC | $114.03 | $120.00(5.24% Upside) | $1.38B | 0.70% | 61Neutral |
 FNDA | $35.98 | $43.35(20.49% Upside) | $9.03B | 0.25% | 68Neutral |
 IJT | $164.34 | $205.69(25.16% Upside) | $7.58B | 0.18% | 68Neutral |
 SLYG | $109.76 | $137.85(25.59% Upside) | $4.77B | 0.15% | 68Neutral |
 VTWG | $256.79 | $375.20(46.11% Upside) | $1.44B | 0.06% | 61Neutral |
 VIOG | $141.44 | $177.51(25.50% Upside) | $1.06B | 0.10% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 114.03 | 19.79 | 21.00% | |
| FNDA | Schwab Fundamental US Small Co. Index ETF | 35.98 | 5.68 | 18.73% | |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 164.34 | 25.54 | 18.40% | |
| SLYG | SPDR S&P 600 Small Cap Growth ETF | 109.76 | 17.26 | 18.65% | |
| VTWG | Vanguard Russell 2000 Growth ETF | 256.79 | 18.73 | 7.87% | |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 141.44 | 22.26 | 18.67% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.